Clinically important drug–drug interactions in primary care

作者: A. A. H. Dhabali , R. Awang , S. H. Zyoud

DOI: 10.1111/J.1365-2710.2011.01314.X

关键词:

摘要: SUMMARY What is known and Objective: Drug–drug interactions (DDIs) cause considerable morbidity mortality worldwide may lead to hospital admission. Sophisticated computerized drug information monitoring systems, more recently established in many of the emerging economies, including Malaysia, are capturing useful on prescribing. Our aim report an investigation potentially serious DDIs, using a university primary care–based system prescription records from its care services. Methods: We retrospectively collected data two academic years over 20 months databases at Universiti Sains Malaysia (USM) users USM Results Discussion: Three hundred eighty-six DDI events were observed cohort 208 exposed patients total 23 733 patients, representing 2-year period prevalence 876AE4 per 100 000 patients. Of 138 (66AE3%) one event, 29 (13AE9%) events, 15 (7AE2%) three 6 (2AE9%) four (9AE6%) than five events. Overall, increasing mean number episodes DDIs was noted among within age category ‡70 (P =0 AE01), trend medications prescribed <0 AE001) long-term therapeutic groups AE001). new Conclusion: describe clinically important economy setting identify common DDIs. In line with observations developed higher seen aged prescribed. The easiest method reduce frequency Therapeutic alternatives should be selected cautiously.

参考文章(31)
Gunter Mj, Young Lr, Hurley Js, Frost Fj, Nelson Ww, Roberts Mh, Solberg Li, Crain Al, Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. The American Journal of Managed Care. ,vol. 10, pp. 753- 759 ,(2004)
J. K Aronson, M. N. G Dukes, Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions Published in <b>2006</b> in Amsterdam Boston by Elsevier. ,(2006)
Chunliu Zhan, Rosaly Correa-de-Araujo, Arlene S. Bierman, Judy Sangl, Marlene R. Miller, Stephen W. Wickizer, Daniel Stryer, Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations. Journal of the American Geriatrics Society. ,vol. 53, pp. 262- 267 ,(2005) , 10.1111/J.1532-5415.2005.53112.X
Thomas K. Hazlet, Todd A. Lee, Philip D. Hansten, John R. Horn, Performance of Community Pharmacy Drug Interaction Software Journal of the American Pharmaceutical Association. ,vol. 41, pp. 200- 204 ,(2001) , 10.1016/S1086-5802(16)31230-X
Philip O. Anderson, James E. Knoben, Handbook of Clinical Drug Data ,(2001)
Jacob Abarca, Daniel C. Malone, Edward P. Armstrong, Amy J. Grizzle, Philip D. Hansten, Robin C. Van Bergen, Richard B. Lipton, Concordance of Severity Ratings Provided in Four Drug Interaction Compendia Journal of The American Pharmacists Association. ,vol. 44, pp. 136- 141 ,(2004) , 10.1331/154434504773062582